Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-05-07

Clinical Trial Update: Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of thalidomide and tegafur/uracil (UFUR) for advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tegafur/Uracil (UFUR) (tegafur/uracil)
  • Thalidomide (thalidomide)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Colon Cancer | Phase 2 | Status: UNKNOWN